GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

KYNB · Mar 31, 2025

KYNTRA BIO, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0000950170-25-069203General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.58% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

99.27% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

-95.10% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

115.19% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

90.80% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-544.72% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

334.98% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

104.13% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building

Sep 30, 20230/7 normalizedLevel 3 Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/8 normalizedLevel 3 Dec 31, 20240/8 normalizedLevel 3 Mar 31, 20250/8 normalizedLevel 3 Jun 30, 20250/8 normalizedLevel 3 Sep 30, 20256/7 normalizedLevel 3 Dec 31, 20257/8 normalizedLevel 3 Mar 31, 20267/8 normalizedLevel 3 Jun 30, 20264/5 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Decreased

Previous: 0.90%
Current: 0.58%
Delta: -0.31%

Cash Generation Increased

Previous: -465.88%
Current: 99.27%
Delta: 565.15%

Growth Decreased

Previous: -79.95%
Current: -95.10%
Delta: -15.15%

Inventory Pressure Increased

Previous: 10.65%
Current: 115.19%
Delta: 104.54%

Margin Increased

Previous: 47.47%
Current: 90.80%
Delta: 43.33%

Profitability Decreased

Previous: -507.80%
Current: -544.72%
Delta: -36.92%

R And D Intensity Increased

Previous: 323.05%
Current: 334.98%
Delta: 11.92%

Sbc Intensity Increased

Previous: 85.13%
Current: 104.13%
Delta: 19.00%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · KYNB Fundamental State →Transitioned To · KYNB PROFITABILITY_DECREASED →Transitioned To · KYNB R_AND_D_INTENSITY_INCREASED →Transitioned To · KYNB SBC_INTENSITY_INCREASED →Transitioned To · KYNB Fundamental State →Transitioned To · KYNB CAPEX_INTENSITY_DECREASED →Transitioned To · KYNB CASH_GENERATION_INCREASED →Transitioned To · KYNB GROWTH_DECREASED →Transitioned To · KYNB INVENTORY_PRESSURE_INCREASED →Transitioned To · KYNB MARGIN_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.